In a NAFLD/NASH mouse model induced by methionine-choline deficient (MCD) and HFD, STING deficiency reduces liver steatosis, fibrosis and inflammation (Luo et al., 2018; Yu et al., 2019). Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.